TP53 and colorectal carcinoma: After excluding patients with missing protein expression data on LDHA, GLUT1, MCT4, PKM2, p53, or PTEN (n = 76), 2268 CRC patients with information on Warburg‐subtype and mutational status were available for analyses (Warburg‐low: n = 646, 28.5%; Warburg‐moderate: n = 820, 36.2%; Warburg‐high: n = 802, 35.4%).